Business · 20/04/2023
FDA Revokes Ebola EUAs for BioFire Defense and Biocartis
The FDA has revoked two Emergency Use Authorizations for Ebola diagnostic devices, issued to BioFire Defense and Biocartis, following a request from each company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →